Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Differin vs Tazorac vs Switch Regimen in Acne Vulgaris
NCT00469755Phase 4Completed
- Sponsor
- Galderma
- Start
- Feb 2006
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of Duac Gel / Differin Gel in acne vulgaris (3 arms), sponsored by Galderma. Primary endpoint: Efficacy - total lesion counts at 12 weeks. Started Feb 2006; status: completed.
02
Drugs
Duac Gel / Differin Gel
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00469755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00469755.